SR
Santosh Reddy Karivedha
About Santosh Reddy Karivedha
Data last updated:
Santosh Reddy Karivedha is a Director at Bionor Pharmaceuticals Private Limited (since 2019). The companies operate in Chemicals and Business Services. Bionor Pharmaceuticals Private Limited reported revenue of ₹3.6 Lakh (FY 2025). Earlier, Santosh Reddy Karivedha was a Director at Gencare Therapeutics India Private Limited (2017–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Nov 2019 | 2019 | ₹3.6 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 May 2017 | 2017 | ₹11.6 Lakh (FY 2019) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Santosh Reddy Karivedha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akash Muduganti | 10881235 | Bionor Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh Reddy Karivedha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh Reddy Karivedha
Santosh Reddy Karivedha currently holds 1 directorship: Bionor Pharmaceuticals Private Limited (Director, since 04 Nov 2019, revenue ₹3.6 Lakh (FY 2025)).
Santosh Reddy Karivedha was first appointed on 19 May 2017 as Director at Gencare Therapeutics India Private Limited. The most recent appointment on record is 04 Nov 2019 at Bionor Pharmaceuticals Private Limited.
Santosh Reddy Karivedha held 1 earlier board appointment: Gencare Therapeutics India Private Limited (Director, 19 May 2017 to 10 Oct 2019).
The current boards of Santosh Reddy Karivedha's companies include Akash Muduganti (Bionor Pharmaceuticals Private Limited).